Scroll Down

To Become a Long-Term Partner
for Global Innovative Biotech Companies

Established in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial drug delivery to global biopharmaceutical innovators.

We offer leading early-stage to late-phase drug discovery expertise by integrating our dedicated team of experts, cutting-edge technology platforms, and state-of-the-art equipment in X-ray crystallization, Cryo-EM, ASMS, SPR, HDX, CADD, etc.. Our business covers all aspects of therapeutic strategies and drug modalities including small molecules and biologics across the pharma and biotech spectrum. Through our subsidiary Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners One-Stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. In addition, Viva has embedded an equity for service (EFS) model to high potential startups to address unmet medical needs.

  • 1,820
    Biotech and pharmaceutical clients worldwide
  • 2,100+
    Employees worldwide
  • 87
    Invested and incubated companies
Drug R&D Services

With its leading position in the field of Structure-Based Drug Discovery (SBDD), Viva provides the state-of-art drug research and development services to global biotechnology and pharmaceutical customers for their preclinical innovative drug discovery programs covering all-round needs of customers for their early drug research and development, including protein expression, purification and structure determination, hits screening, therapeutic antibody discovery, antibody expression and production, Bioassay, computer-aided drug design, medicinal  chemistry and custom synthesis, ADME and PK studies.

Learn more
R&D and Production Services
As the subsidiary of Viva Biotech holdings, Langhua offers our worldwide partners One-Stop CDMO solution in new drug full life-cycle for small molecule Active Pharmaceutical Ingredients (APIs) and Finished Dosage Form, from pre-clinical to commercial supply.
Learn more

One-stop services ranging from early-stage Structure-Based Drug R&D to commercial drug delivery

Subscribe to Our Newsletter
This site uses cookies and your privacy choices are important to us
We use cookies to improve the user experience and to analyze website traffic. By clicking "Accept", you consent to the use of cookies on our website, such as cookies policies.
Thank you for your subscription
You will receive regular push from via bio via email.
Subscription failed. Please try again later.
Illegal attempt, please refresh
Please enter the correct email number